These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 416945)

  • 41. Acid maltase deficiency: a case study and review of the pathophysiological changes and proposed therapeutic measures.
    Isaacs H; Savage N; Badenhorst M; Whistler T
    J Neurol Neurosurg Psychiatry; 1986 Sep; 49(9):1011-8. PubMed ID: 3093639
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Three hypotonic neonates with hypertrophic cardiomyopathy: Pompe's disease].
    Willemsen MA; Jira PE; Gabreëls FJ; van der Ploeg AT; Smeitink JA
    Ned Tijdschr Geneeskd; 1998 Jun; 142(24):1388-92. PubMed ID: 9752027
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pompe's disease.
    Joshi RM; Mohire MD; Bharucha BA; Kumta NB; Desai AP; Desai AD
    Indian Pediatr; 1985 Apr; 22(4):315-8. PubMed ID: 2422123
    [No Abstract]   [Full Text] [Related]  

  • 44. The endocrine glands in Pompe's disease. Report of two cases.
    Hui KS; Williams JC; Borit A; Rosenberg HS
    Arch Pathol Lab Med; 1985 Oct; 109(10):921-5. PubMed ID: 3899054
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Acid maltase deficiency in 2 adolescent siblings].
    Gracia P; Benlloch T; de la Fuente G; Durántez A; Espanña P; Cánovas A; Illera ER
    Med Clin (Barc); 1982 Sep; 79(5):227-31. PubMed ID: 6755088
    [No Abstract]   [Full Text] [Related]  

  • 46. Thin-layer chromatography of oligosaccharides in urine as a rapid indication for the diagnosis of lysosomal acid maltase deficiency (Pompe's disease).
    Blom W; Luteyn JC; Kelholt-Dijkman HH; Huijmans JG; Loonen MC
    Clin Chim Acta; 1983 Oct; 134(1-2):221-7. PubMed ID: 6418415
    [No Abstract]   [Full Text] [Related]  

  • 47. [Severe form of juvenile type II glycogenosis in a compound-heterozygous boy (Tyr-292--> Cys/Arg-854-->Stop)].
    Castro-Gago M; Eirís-Puñal J; Rodríguez-Núñez A; Pintos-Martínez E; Benlloch-Marín T; Barros-Angueira F
    Rev Neurol; 1999 Jul 1-15; 29(1):46-9. PubMed ID: 10528311
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The significance of pathological spontaneous activity in various myopathies.
    Hanisch F; Kronenberger C; Zierz S; Kornhuber M
    Clin Neurophysiol; 2014 Jul; 125(7):1485-90. PubMed ID: 24370491
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Pompe's disease. Part I: pathogenesis and clinical features].
    Illés Z; Trauninger A
    Ideggyogy Sz; 2009 Jul; 62(7-8):231-43. PubMed ID: 19685701
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enzyme replacement therapy in late-onset Pompe's disease: a three-year follow-up.
    Winkel LP; Van den Hout JM; Kamphoven JH; Disseldorp JA; Remmerswaal M; Arts WF; Loonen MC; Vulto AG; Van Doorn PA; De Jong G; Hop W; Smit GP; Shapira SK; Boer MA; van Diggelen OP; Reuser AJ; Van der Ploeg AT
    Ann Neurol; 2004 Apr; 55(4):495-502. PubMed ID: 15048888
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Myopathy due to acid maltase deficiency. Pompe's disease in adolescence and adult (author's transl)].
    Kölmel HW; Assmus H; Seiler D
    Arch Psychiatr Nervenkr (1970); 1974; 218(2):93-106. PubMed ID: 4522354
    [No Abstract]   [Full Text] [Related]  

  • 52. [Differential diagnosis in anorexia nervosa: glycogenosis II (the Pompe type)].
    Fischer P; Eich W; Haass M; Herzog W
    Dtsch Med Wochenschr; 1999 Aug; 124(31-32):925-9. PubMed ID: 10480012
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Glycogen storage disease type II (Pompe's disease): the first biochemical evidence in Thailand.
    Rangdaeng S; Scollard DM; Srichairatanakol S; Sutthachit M; Phornphutkul C
    J Med Assoc Thai; 1987 Sep; 70(9):536-42. PubMed ID: 2960768
    [No Abstract]   [Full Text] [Related]  

  • 54. Clinical diversity in glycogenosis type II. Biosynthesis and in situ localization of acid alpha-glucosidase in mutant fibroblasts.
    Reuser AJ; Kroos M; Willemsen R; Swallow D; Tager JM; Galjaard H
    J Clin Invest; 1987 Jun; 79(6):1689-99. PubMed ID: 3108320
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Very early presentation of Pompe's disease and its cross-sectional echocardiographic features.
    Lorber A; Luder AS
    Int J Cardiol; 1987 Sep; 16(3):311-4. PubMed ID: 3308716
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Glycogen storage disease type II in Israel.
    Bashan N; Potashnik R; Barash V; Gutman A; Moses SW
    Isr J Med Sci; 1988; 24(4-5):224-7. PubMed ID: 3132435
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Generalized glycogenosis (Pompe's disease) in an 11-year-old girl].
    Rozenberg VD
    Arkh Patol; 1978; 40(9):69-71. PubMed ID: 280283
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A micro-radiochemical assay for alpha-1,4-glucosidase and its use in the assessment of type II glycogenosis (Pompe's disease).
    Nelson PV; Carey WF; Pollard AC
    Clin Chim Acta; 1977 Jun; 77(3):337-42. PubMed ID: 17494
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A sensitive semi-automated kinetic assay of alpha-D-glucosidase for the prenatal diagnosis of type 2 glycogenosis (Pompe's disease).
    Blau K
    J Inherit Metab Dis; 1978; 1(3):85-8. PubMed ID: 116083
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Enzyme replacement therapy in Pompe's disease].
    Merk T; Wibmer T; Schumann C; Krüger S
    Med Klin (Munich); 2007 Jul; 102(7):570-3. PubMed ID: 17634875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.